Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 358

1.

Simultaneous Resection of High-risk Liver Tumors and Pulmonary Metastases in Children.

Urla C, Seitz G, Tsiflikas I, Handgretinger R, Fideler F, Neunhoeffer F, Warmann SW, Fuchs J.

Ann Surg. 2015 Feb 25. [Epub ahead of print] No abstract available.

PMID:
25719810
[PubMed - as supplied by publisher]
2.

Human Peripheral CD4(+) Vδ1(+) γδT Cells Can Develop into αβT Cells.

Ziegler H, Welker C, Sterk M, Haarer J, Rammensee HG, Handgretinger R, Schilbach K.

Front Immunol. 2014 Dec 17;5:645. doi: 10.3389/fimmu.2014.00645. eCollection 2014.

PMID:
25709606
[PubMed]
Free PMC Article
3.

Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.

Döring M, Eikemeier M, Cabanillas Stanchi KM, Hartmann U, Ebinger M, Schwarze CP, Schulz A, Handgretinger R, Müller I.

Eur J Clin Microbiol Infect Dis. 2015 Feb 14. [Epub ahead of print]

PMID:
25680318
[PubMed - as supplied by publisher]
4.

Adoptive T-cell therapy with hexon-specific THELPER-1 cells as a treatment for refractory adenovirus infection after HSCT.

Feucht J, Opherk K, Lang P, Kayser S, Hartl L, Bethge W, Matthes-Martin S, Bader P, Albert MH, Maecker-Kolhoff B, Greil J, Einsele H, Schlegel PG, Schuster FR, Kremens B, Rossig C, Gruhn B, Handgretinger R, Feuchtinger T.

Blood. 2015 Jan 23. pii: blood-2014-06-573725. [Epub ahead of print]

PMID:
25617426
[PubMed - as supplied by publisher]
5.

A functional inflammasome activation assay differentiates patients with pathogenic NLRP3 mutations and symptomatic patients with low penetrance variants.

Rieber N, Gavrilov A, Hofer L, Singh A, Öz H, Endres T, Schäfer I, Handgretinger R, Hartl D, Kuemmerle-Deschner J.

Clin Immunol. 2015 Jan 14;157(1):56-64. doi: 10.1016/j.clim.2015.01.003. [Epub ahead of print]

PMID:
25596455
[PubMed - as supplied by publisher]
6.

Patterns of monocyte subpopulations and their surface expression of HLA-DR during adverse events after hematopoietic stem cell transplantation.

Döring M, Cabanillas Stanchi KM, Haufe S, Erbacher A, Bader P, Handgretinger R, Hofbeck M, Kerst G.

Ann Hematol. 2014 Dec 30. [Epub ahead of print]

PMID:
25544031
[PubMed - as supplied by publisher]
7.

Arabinoxylan rice bran (MGN-3/Biobran) enhances natural killer cell-mediated cytotoxicity against neuroblastoma in vitro and in vivo.

Pérez-Martínez A, Valentín J, Fernández L, Hernández-Jiménez E, López-Collazo E, Zerbes P, Schwörer E, Nuñéz F, Martín IG, Sallis H, Díaz MÁ, Handgretinger R, Pfeiffer MM.

Cytotherapy. 2014 Dec 22. pii: S1465-3249(14)00849-4. doi: 10.1016/j.jcyt.2014.11.001. [Epub ahead of print]

PMID:
25541298
[PubMed - as supplied by publisher]
8.

Phagocytic activity of monocytes, their subpopulations and granulocytes during post-transplant adverse events after hematopoietic stem cell transplantation.

Döring M, Cabanillas Stanchi KM, Erbacher A, Haufe S, Schwarze CP, Handgretinger R, Hofbeck M, Kerst G.

Immunobiology. 2014 Dec 15. pii: S0171-2985(14)00271-X. doi: 10.1016/j.imbio.2014.12.002. [Epub ahead of print]

PMID:
25541241
[PubMed - as supplied by publisher]
9.

γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay.

Seidel UJ, Vogt F, Grosse-Hovest L, Jung G, Handgretinger R, Lang P.

Front Immunol. 2014 Dec 2;5:618. doi: 10.3389/fimmu.2014.00618. eCollection 2014.

PMID:
25520723
[PubMed]
Free PMC Article
10.

Children with relapsed or refractory nephroblastoma: favorable long-term survival after high-dose chemotherapy and autologous stem cell transplantation.

Illhardt T, Ebinger M, Schwarze CP, Feuchtinger T, Furtwängler R, Schlegel PG, Klingebiel T, Greil J, Beck JF, Handgretinger R, Lang P.

Klin Padiatr. 2014 Nov;226(6-7):351-6. doi: 10.1055/s-0034-1390504. Epub 2014 Nov 28.

PMID:
25431868
[PubMed - in process]
Free Article
11.

Selective, efficient modulation of activated CD4+ αβT cells by the novel humanized antibody GZ-αβTCR targeting human αβTCR.

Blank G, Welker C, Haarer J, Sterk M, Nadalin S, Yañez VA, Joos TO, Menrad A, Snell D, LaCorcia G, Königsrainer A, Handgretinger R, Schilbach K.

Bone Marrow Transplant. 2014 Nov 17. doi: 10.1038/bmt.2014.263. [Epub ahead of print]

PMID:
25402416
[PubMed - as supplied by publisher]
12.

Both mature KIR+ and immature KIR- NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdcscid IL2rgtmWjl/Sz mice.

Kübler A, Woiterski J, Witte KE, Bühring HJ, Hartwig UF, Ebinger M, Oevermann L, Mezger M, Herr W, Lang P, Handgretinger R, Münz C, André MC.

Blood. 2014 Dec 18;124(26):3914-23. doi: 10.1182/blood-2014-05-572743. Epub 2014 Oct 30.

PMID:
25359989
[PubMed - indexed for MEDLINE]
13.

Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma.

Dantonello TM, Stark M, Timmermann B, Fuchs J, Selle B, Linderkamp C, Handgretinger R, Hagen R, Feuchtgruber S, Kube S, Kosztyla D, Kazanowska B, Ladenstein R, Niggli F, Ljungman G, Bielack SS, Klingebiel T, Koscielniak E; Cooperative Weichteilsarkom Studiengruppe [CWS].

Pediatr Blood Cancer. 2015 Jan;62(1):16-23. doi: 10.1002/pbc.25207. Epub 2014 Sep 27.

PMID:
25263634
[PubMed - indexed for MEDLINE]
14.

Differential expression of THELPER 1 cytokines upon antigen stimulation predicts ex vivo proliferative potential and cytokine production of virus-specific T cells following re-stimulation.

Feucht J, Leibold J, Halder A, Kayser S, Hartl L, Rammensee HG, Handgretinger R, Feuchtinger T.

Transpl Infect Dis. 2014 Oct;16(5):713-23. doi: 10.1111/tid.12281. Epub 2014 Sep 9.

PMID:
25200928
[PubMed - in process]
15.

Monocyte-induced development of Th17 cells and the release of S100 proteins are involved in the pathogenesis of graft-versus-host disease.

Reinhardt K, Foell D, Vogl T, Mezger M, Wittkowski H, Fend F, Federmann B, Gille C, Feuchtinger T, Lang P, Handgretinger R, Andreas Bethge W, Holzer U.

J Immunol. 2014 Oct 1;193(7):3355-65. doi: 10.4049/jimmunol.1400983. Epub 2014 Sep 3.

PMID:
25187661
[PubMed - indexed for MEDLINE]
16.

KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL.

Oevermann L, Michaelis SU, Mezger M, Lang P, Toporski J, Bertaina A, Zecca M, Moretta L, Locatelli F, Handgretinger R.

Blood. 2014 Oct 23;124(17):2744-7. doi: 10.1182/blood-2014-03-565069. Epub 2014 Aug 12.

PMID:
25115891
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation.

Döring M, Rohrer KM, Erbacher A, Gieseke F, Schwarze CP, Bader P, Handgretinger R, Hofbeck M, Kerst G.

Ann Hematol. 2015 Feb;94(2):265-73. doi: 10.1007/s00277-014-2185-y. Epub 2014 Aug 13.

PMID:
25113134
[PubMed - in process]
18.

Haploidentical transplantation: the search for the best donor.

Handgretinger R.

Blood. 2014 Aug 7;124(6):827-8. doi: 10.1182/blood-2014-06-582460. No abstract available.

PMID:
25104858
[PubMed - in process]
Free PMC Article
19.

Will Post-Transplantation Cell Therapies for Pediatric Patients Become Standard of Care?

Lankester AC, Locatelli F, Bader P, Rettinger E, Egeler M, Katewa S, Pulsipher MA, Nierkens S, Schultz K, Handgretinger R, Grupp SA, Boelens JJ, Bollard CM; Westhafen Intercontinental Group.

Biol Blood Marrow Transplant. 2015 Mar;21(3):402-411. doi: 10.1016/j.bbmt.2014.07.018. Epub 2014 Jul 23. Review.

PMID:
25064748
[PubMed - as supplied by publisher]
20.

How an accidental discovery paved the way for the treatment of complicated infantile haemangiomas.

Handgretinger R.

Acta Paediatr. 2014 Sep;103(9):896-7. doi: 10.1111/apa.12715. Epub 2014 Jul 7. No abstract available.

PMID:
25040099
[PubMed - in process]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk